Stock Alert: Taiwan Liposome Gains 30% On Approval To Initiate COVID-19 Treatment Trial

By RTTNews Staff Writer   ✉   | Published:

Shares of Taiwan Liposome Company, Ltd. (TLC) jumped over 30% on Wednesday morning after the company received approval in Australia to initiate phase 1 trial of COVID-19 treatment.

TLC is currently trading at $5.77, up $1.42 or 32.64%, on the Nasdaq.

The clinical-stage pharmaceutical company announced it received ethical and scientific approval from the Bellberry Human Research Ethics Committee in Australia for its phase I clinical trial of TLC19 Hydroxychloroquine Liposome Inhalation Suspension for COVID-19.

The phase 1 study will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses of inhaled TLC19 in 30 healthy volunteers.

The approval comes after the acceptance of TLC's investigational new drug application with the Taiwan Food and Drug Administration yesterday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Disney Splits Media And Entertainment Businesses To Accelerate DTC Strategy
Walt Disney Co. is reorganizing its media and entertainment businesses aiming to accelerate its direct-to-consumer or DTC strategy following the significant success of its streaming service Disney+. In a statement, the company stated that its media and entertainment businesses will be separated into creative engines, as well as Media and Entertainment Distribution Group.
J&J Pauses Late-stage COVID-19 Vaccine Trial On Unexplained Illness
Johnson & Johnson (JNJ) has paused the phase III study of its COVID-19 vaccine candidate, JNJ-78436735, due to an unexplained illness in a study participant, Stat News reported, citing a document sent to outside researchers running the 60,000-patient clinical trial.
Twitter Takes Additional Steps To Prevent Interference In US Election
Twitter has taken additional steps to prevent any manipulation or interference in the upcoming U.S. Elections or other civic processes through misleading Tweets. It announced significant product and enforcement updates to enable the smooth conduct of the democratic process. The social media platform has recently expanded its civic integrity policy to address misleading information.